Preventing local complications of depot neuroleptics
Muldoon, C.
Bmj 311(7016): 1368
1995
ISSN/ISBN: 0959-8138 PMID: 7496300 Document Number: 450136
Document emailed within 1 workday
Related Documents
Simpson, G.M. 1984: A brief history of depot neuroleptics Journal of Clinical Psychiatry 45(5 Part 2): 3-4Paolucci, S.; Buttinelli, C.; Fiume, S.; Ciani, S.; Lenzi, G.L. 1984: Treatment of Gilles de la Tourette syndrome with depot neuroleptics Acta Neurologica 6(3): 222-224
Taussigová, D.; Prokopová, Z.; Bastecký, J.; Vinar, O. 1973: Experience with long-acting depot--neuroleptics in schizophrenic psychoses Activitas Nervosa Superior 15(2): 83-84
Bobes, J.; González, M.P.; Sáiz, P.A.; Octavio, I.; Fernández, J.M.; Bousoño, M. 2000: Risperidone: a real alternative for patients treated with depot neuroleptics Actas Espanolas de Psiquiatria 28(6): 367-372
Dencker, S.J. 1984: The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective Journal of Clinical Psychiatry 45(5 Part 2): 22-27
Lindholm, H.; Ljungberg, L. 1973: Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation Acta Psychiatrica Scandinavica. Supplementum 246: 52-56
Bjørndal, F.; Lauritsen, B.; Lyngbye, J.; Waarst, S. 1979: Serum creatine kinase in patients treated with depot neuroleptics. a pilot study Ugeskrift for Laeger 141(51): 3514-3516
Bergener, M.; Husser, J.; Kranzhoff, E.U.; Charap, A. 1986: Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients Fortschritte der Medizin 104(40): 756-760
Hauswirth, R. 1983: Lumbosacral backaches. Treatment using local infiltration with local anesthetics and depot corticosteroids Zfa. Zeitschrift für Allgemeinmedizin 59(18): 1034-1040
Eufe, R.; Wegener, G. 1979: Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia Der Nervenarzt 50(8): 534-539
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Mühlberger, G.; Huch, A. 1974: Thromboembolic complications in radiotherapy. Influence of Depot-Eleparon prevention and radium insertion-time on the incidence and course of thromboembolic complications Fortschritte der Medizin 92(31): 1274-1276
Destee, A.; Montagne, B.; Rousseaux, M.; Petit, H.; Warot, P. 1980: Effects and complications of neuroleptics (110 hospitalizations in neurology) Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 25(6): 291-295
Bak, K.; Haugegaard, M.; Heltberg, O. 1993: Purulent arthritis and bursitis after local injection of depot steroids Ugeskrift for Laeger 155(14): 1047-1049
Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Neuroleptics and thymoleptics. 3.1 Neuroleptics Fortschritte der Medizin 101(40): 1823; 1826-1827
von Schrader, H.W.; Buscher, G.; Dierdorf, D.; Freytag, A.; Mügge, H.; Wolf, D. 1985: Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets Arzneimittel-Forschung 35(9): 1468-1472
Borisenko, K.K.; Glozman, V.N.; Nazarova, A.Iu. 1988: A method for preventing postpuncture complications Vestnik Dermatologii i Venerologii 1988(8): 69-70
Lefevre, M.L. 1992: Preventing the complications of preterm birth American Family Physician 46(2): 441-448
2007: Preventing catheter-related infectious complications Journal of Supportive Oncology 5(2): 70-71
Kühnie, H.; Grande, P.; Kuhn, W. 1977: Preventing complications due to dilatation by intracervical application of a prostaglandin-gel Geburtshilfe und Frauenheilkunde 37(8): 675-680